OnabotulinumtoxinA: Still the Present for Chronic Migraine

OnabotulinumtoxinA (BT-A) is one of the few drugs approved for the preventive treatment of chronic migraine (CM). Despite this, some aspects of its mechanism of action are still a matter of debate, and the precise magnitude of BT-A effects needs to be completely elucidated. BT-A acts primarily upon...

Descripción completa

Detalles Bibliográficos
Autores principales: Baraldi, Carlo, Lo Castro, Flavia, Ornello, Raffaele, Sacco, Simona, Pani, Luca, Guerzoni, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865956/
https://www.ncbi.nlm.nih.gov/pubmed/36668879
http://dx.doi.org/10.3390/toxins15010059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865956/
https://www.ncbi.nlm.nih.gov/pubmed/36668879
http://dx.doi.org/10.3390/toxins15010059

Ejemplares similares